OMEPRAZOLE AND SODIUM BICARBONATE

OMEPRAZOLE AND SODIUM BICARBONATE was reported 2817 times

OMEPRAZOLE AND SODIUM BICARBONATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLOOD AMYLASE DECREASED 3 0.0600
1 BENIGN VAGINAL NEOPLASM 2 0.0556
2 DIABETIC END STAGE RENAL DISEASE 2 0.0385
3 RENAL HAMARTOMA 2 0.0357
4 ISCHAEMIC NEPHROPATHY 2 0.0260
5 DEVICE DEPENDENCE 4 0.0255
6 RENAL ARTERY ARTERIOSCLEROSIS 3 0.0236
7 RENAL HYPERTENSION 7 0.0225
8 HYPERTENSIVE NEPHROPATHY 24 0.0225
9 INSULIN C-PEPTIDE INCREASED 3 0.0216
10 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 22 0.0207
11 REBOUND ACID HYPERSECRETION 59 0.0195
12 NEPHROGENIC ANAEMIA 73 0.0157
13 HYPERPARATHYROIDISM SECONDARY 37 0.0148
14 PROSTATIC OBSTRUCTION 2 0.0119
15 END STAGE RENAL DISEASE 212 0.0116
16 BENIGN RENAL NEOPLASM 2 0.0116
17 CONGENITAL RENAL DISORDER 3 0.0113
18 BILIARY DYSKINESIA 19 0.0112
19 GALLBLADDER CHOLESTEROLOSIS 5 0.0110
20 CHRONIC KIDNEY DISEASE 788 0.0104
21 TOBACCO ABUSE 5 0.0094
22 METABOLIC FUNCTION TEST ABNORMAL 3 0.0091
23 URETHRAL STENOSIS 6 0.0088
24 RENAL HAEMANGIOMA 7 0.0088
25 RENAL ARTERIOSCLEROSIS 2 0.0082
26 CHOLESTEROSIS 2 0.0078
27 CARDITIS 3 0.0072
28 RENAL INJURY 195 0.0066
29 FEEDING TUBE COMPLICATION 2 0.0064
30 CALCIUM DEFICIENCY 8 0.0062
31 GASTRIC MUCOSA ERYTHEMA 2 0.0060
32 GASTROINTESTINAL MICROORGANISM OVERGROWTH 2 0.0057
33 BIPOLAR II DISORDER 2 0.0056
34 LOWER URINARY TRACT SYMPTOMS 2 0.0055
35 DIABETIC NEPHROPATHY 12 0.0054
36 NEPHROSCLEROSIS 6 0.0054
37 TUBULOINTERSTITIAL NEPHRITIS 101 0.0054
38 CHOLECYSTITIS CHRONIC 36 0.0054
39 NEPHROPATHY 50 0.0053
40 URINE COLOUR ABNORMAL 3 0.0053
41 GLOMERULOSCLEROSIS 3 0.0047
42 BLOOD HOMOCYSTEINE INCREASED 2 0.0047
43 RENAL ARTERY STENOSIS 6 0.0044
44 ADRENAL NEOPLASM 2 0.0043
45 PELVIC FLUID COLLECTION 3 0.0043
46 FUNGAL OESOPHAGITIS 3 0.0043
47 METAPLASIA 2 0.0042
48 NEPHROCALCINOSIS 5 0.0042
49 RENAL ATROPHY 5 0.0040
50 SALIVARY GLAND ENLARGEMENT 2 0.0038
51 ALBUMINURIA 2 0.0037
52 CARDIORENAL SYNDROME 2 0.0035
53 ORTHOSTATIC HYPERTENSION 2 0.0034
54 RENAL TUBULAR ATROPHY 3 0.0034
55 HYPERCHLORHYDRIA 20 0.0034
56 NEPHRECTOMY 5 0.0034
57 GASTROINTESTINAL POLYP HAEMORRHAGE 2 0.0033
58 RENAL CYST 26 0.0033
59 RENAL FAILURE 431 0.0032
60 LOWER EXTREMITY MASS 2 0.0032
61 MEDICAL DEVICE SITE INFECTION 2 0.0032
62 BLOOD CORTISOL DECREASED 2 0.0031
63 RENAL SURGERY 2 0.0031
64 ACUTE KIDNEY INJURY 456 0.0030
65 PAINFUL DEFAECATION 2 0.0029
66 INTRACRANIAL VENOUS SINUS THROMBOSIS 3 0.0028
67 TOXOPLASMOSIS 3 0.0028
68 FIBROCYSTIC BREAST DISEASE 2 0.0027
69 ALLERGIC COUGH 2 0.0026
70 GALLBLADDER INJURY 5 0.0026
71 GRIMACING 2 0.0026
72 HYPOCHLORAEMIA 3 0.0026
73 GRANULOMATOSIS WITH POLYANGIITIS 3 0.0025
74 BARRETT'S OESOPHAGUS 2 0.0025
75 HEAT EXHAUSTION 2 0.0025
76 PARATHYROID DISORDER 2 0.0025
77 PERIORBITAL HAEMATOMA 2 0.0024
78 RENAL MASS 5 0.0024
79 BLOOD UREA DECREASED 3 0.0024
80 CONGENITAL CYSTIC KIDNEY DISEASE 2 0.0024
81 EROSIVE OESOPHAGITIS 4 0.0024
82 OBSTRUCTION GASTRIC 3 0.0023
83 ADENOMA BENIGN 2 0.0023
84 PROTEIN URINE 2 0.0022
85 OESOPHAGEAL STENOSIS 6 0.0021
86 ATROPHY 4 0.0021
87 COLON ADENOMA 2 0.0020
88 GASTRECTOMY 2 0.0020
89 VITAMIN D DEFICIENCY 19 0.0019
90 AORTIC ARTERIOSCLEROSIS 5 0.0019
91 INCORRECT PRODUCT ADMINISTRATION DURATION 42 0.0019
92 LIGHT CHAIN ANALYSIS INCREASED 2 0.0019
93 GASTROOESOPHAGEAL REFLUX DISEASE 156 0.0019
94 BLOOD PHOSPHORUS DECREASED 7 0.0019
95 CYSTITIS INTERSTITIAL 3 0.0019
96 BLADDER DILATATION 2 0.0018
97 AORTIC DILATATION 2 0.0018
98 RENAL COLIC 4 0.0018
99 ACUTE SINUSITIS 3 0.0017
100 LUMBAR RADICULOPATHY 2 0.0017
101 DILATATION ATRIAL 2 0.0017
102 FEAR OF DISEASE 3 0.0017
103 CREPITATIONS 5 0.0017
104 INFECTED CYST 2 0.0017
105 NOCTURIA 20 0.0016
106 ESSENTIAL HYPERTENSION 3 0.0016
107 RENAL TUBULAR NECROSIS 16 0.0016
108 DUODENITIS 5 0.0016
109 HYPERTENSIVE HEART DISEASE 3 0.0016
110 PLATELET DISORDER 4 0.0016
111 NASAL SEPTUM DEVIATION 3 0.0015
112 PYELONEPHRITIS 13 0.0015
113 FOAMING AT MOUTH 3 0.0015
114 RENAL HAEMORRHAGE 3 0.0015
115 DIALYSIS 20 0.0014
116 NOROVIRUS INFECTION 2 0.0014
117 EXPOSED BONE IN JAW 3 0.0014
118 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 2 0.0014
119 SPINAL OSTEOARTHRITIS 12 0.0014
120 BILIARY DILATATION 2 0.0014
121 GENERALISED ANXIETY DISORDER 2 0.0014
122 PRECANCEROUS SKIN LESION 2 0.0014
123 RHINITIS ALLERGIC 6 0.0013
124 ADHESION 2 0.0013
125 ASTIGMATISM 2 0.0013
126 THROMBOPHLEBITIS SUPERFICIAL 4 0.0013
127 NEPHROTIC SYNDROME 9 0.0013
128 CALCULUS URINARY 2 0.0013
129 LICHEN PLANUS 3 0.0013
130 OSTEOSCLEROSIS 2 0.0013
131 INTESTINAL OPERATION 2 0.0013
132 URINARY HESITATION 3 0.0013
133 URINE FLOW DECREASED 3 0.0013
134 RADIUS FRACTURE 3 0.0012
135 METABOLIC SYNDROME 2 0.0012
136 COLONIC POLYP 2 0.0012
137 DEVICE INFUSION ISSUE 3 0.0012
138 SOCIAL PROBLEM 5 0.0012
139 WOUND DEHISCENCE 4 0.0012
140 GALLBLADDER DISORDER 21 0.0012
141 BLOOD MAGNESIUM DECREASED 10 0.0012
142 TEMPOROMANDIBULAR JOINT SYNDROME 3 0.0011
143 PRE-EXISTING CONDITION IMPROVED 7 0.0011
144 VASCULAR DEVICE INFECTION 5 0.0011
145 ORAL FUNGAL INFECTION 3 0.0011
146 MAJOR DEPRESSION 8 0.0011
147 INTERVERTEBRAL DISC DEGENERATION 10 0.0011
148 REBOUND EFFECT 12 0.0011
149 BILE DUCT OBSTRUCTION 2 0.0011
150 PHARYNGEAL DISORDER 3 0.0010
151 HYPOGLYCAEMIC COMA 3 0.0010
152 OESOPHAGEAL ULCER 4 0.0010
153 OESOPHAGEAL DISORDER 4 0.0010
154 RALES 6 0.0010
155 DEVICE POWER SOURCE ISSUE 3 0.0010
156 NAIL DISCOLOURATION 4 0.0010
157 VULVOVAGINAL MYCOTIC INFECTION 4 0.0010
158 HIATUS HERNIA 13 0.0010
159 AZOTAEMIA 4 0.0010
160 MUCOSAL DRYNESS 2 0.0010
161 ECONOMIC PROBLEM 15 0.0010
162 MUSCLE CONTRACTURE 2 0.0010
163 HYPERPARATHYROIDISM 2 0.0010
164 FAMILY STRESS 3 0.0010
165 ANAL PRURITUS 2 0.0010
166 CHOLECYSTECTOMY 11 0.0010
167 LEFT VENTRICULAR HYPERTROPHY 4 0.0009
168 INFUSION SITE HAEMORRHAGE 3 0.0009
169 CATHETERISATION CARDIAC 4 0.0009
170 OSTEOPOROSIS 37 0.0009
171 APPLICATION SITE URTICARIA 2 0.0009
172 GASTRIC POLYPS 2 0.0009
173 HEPATIC CYST 3 0.0009
174 MICTURITION URGENCY 10 0.0009
175 SPINAL COLUMN STENOSIS 4 0.0008
176 PULMONARY INFARCTION 2 0.0008
177 FIBRIN D DIMER INCREASED 3 0.0008
178 HYPERLIPIDAEMIA 10 0.0008
179 GASTROINTESTINAL OBSTRUCTION 2 0.0008
180 GLOMERULONEPHRITIS 2 0.0008
181 DIABETIC NEUROPATHY 4 0.0008
182 HEART INJURY 2 0.0008
183 GASTROINTESTINAL TUBE INSERTION 2 0.0008
184 URINE OUTPUT DECREASED 7 0.0008
185 INFUSION SITE SWELLING 5 0.0008
186 MULTIPLE FRACTURES 13 0.0008
187 LABYRINTHITIS 2 0.0008
188 DYSLIPIDAEMIA 4 0.0008
189 PARKINSON'S DISEASE 2 0.0008
190 PRODUCT TEMPERATURE EXCURSION ISSUE 4 0.0008
191 MENOPAUSE 2 0.0008
192 CONCUSSION 6 0.0008
193 THERAPEUTIC PRODUCT EFFECT VARIABLE 3 0.0008
194 LIPOMA 2 0.0008
195 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 2 0.0008
196 PROSTATOMEGALY 3 0.0008
197 OESOPHAGEAL PAIN 3 0.0008
198 BREAST SWELLING 2 0.0007
199 EAR CONGESTION 2 0.0007
200 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 4 0.0007
201 TRIGGER FINGER 3 0.0007
202 POLYURIA 6 0.0007
203 GOITRE 3 0.0007
204 ATELECTASIS 7 0.0007
205 MACULE 2 0.0007
206 NEPHROLITHIASIS 33 0.0007
207 RESTLESS LEGS SYNDROME 13 0.0007
208 BONE DISORDER 13 0.0007
209 INFUSION SITE ERYTHEMA 6 0.0007
210 BUNDLE BRANCH BLOCK LEFT 3 0.0007
211 RENAL IMPAIRMENT 59 0.0007
212 FIBULA FRACTURE 2 0.0007
213 LUNG CANCER METASTATIC 2 0.0007
214 HYPERTONIC BLADDER 2 0.0007
215 PULMONARY FUNCTION TEST DECREASED 3 0.0007
216 LUMBAR SPINAL STENOSIS 2 0.0007
217 NECK INJURY 2 0.0007
218 PLEURISY 4 0.0007
219 CHOLECYSTITIS 8 0.0007
220 HYDRONEPHROSIS 5 0.0007
221 INCONTINENCE 7 0.0007
222 RENAL PAIN 7 0.0007
223 URINE ABNORMALITY 3 0.0007
224 OSTEOPENIA 10 0.0007
225 ISCHAEMIC CARDIOMYOPATHY 2 0.0007
226 BLOOD CHOLESTEROL ABNORMAL 3 0.0006
227 BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0006
228 DIASTOLIC DYSFUNCTION 2 0.0006
229 HYPOMAGNESAEMIA 9 0.0006
230 GASTRITIS EROSIVE 3 0.0006
231 PERFORMANCE STATUS DECREASED 3 0.0006
232 BLOOD CREATININE DECREASED 2 0.0006
233 RESPIRATORY RATE DECREASED 2 0.0006
234 ABDOMINAL ADHESIONS 2 0.0006
235 SARCOIDOSIS 3 0.0006
236 PROTEINURIA 12 0.0006
237 BLADDER PAIN 2 0.0006
238 SLEEP APNOEA SYNDROME 12 0.0006
239 ORTHOPNOEA 2 0.0006
240 APHAGIA 3 0.0006
241 LOOSE TOOTH 2 0.0006
242 POSTURE ABNORMAL 2 0.0006
243 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
244 DYSGRAPHIA 4 0.0006
245 OTITIS MEDIA 2 0.0006
246 PEPTIC ULCER 2 0.0006
247 HIGH DENSITY LIPOPROTEIN DECREASED 2 0.0006
248 LYME DISEASE 2 0.0006
249 PRODUCT PRESCRIBING ISSUE 13 0.0006
250 HAEMODIALYSIS 5 0.0006
251 IMPAIRED GASTRIC EMPTYING 8 0.0006
252 INCREASED UPPER AIRWAY SECRETION 3 0.0006
253 EYE MOVEMENT DISORDER 4 0.0006
254 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
255 RENAL DISORDER 27 0.0006
256 AORTIC STENOSIS 2 0.0006
257 CAROTID ARTERY STENOSIS 2 0.0006
258 GASTRITIS 15 0.0006
259 KIDNEY INFECTION 11 0.0006
260 FRUSTRATION 2 0.0006
261 GOUT 10 0.0006
262 RENAL TRANSPLANT 2 0.0006
263 POLLAKIURIA 23 0.0006
264 SCLERODERMA 2 0.0005
265 OESOPHAGITIS 6 0.0005
266 INTERVERTEBRAL DISC PROTRUSION 12 0.0005
267 CHOLELITHIASIS 18 0.0005
268 ROTATOR CUFF SYNDROME 7 0.0005
269 DYSURIA 20 0.0005
270 INFUSION SITE PAIN 7 0.0005
271 INJURY 38 0.0005
272 NERVE INJURY 6 0.0005
273 FEELING DRUNK 4 0.0005
274 HYPERACUSIS 2 0.0005
275 MITRAL VALVE INCOMPETENCE 6 0.0005
276 CHOLECYSTITIS ACUTE 3 0.0005
277 FOOT FRACTURE 10 0.0005
278 HAEMATURIA 18 0.0005
279 FEELING JITTERY 10 0.0005
280 PARANASAL SINUS HYPERSECRETION 2 0.0005
281 GASTRIC INFECTION 2 0.0005
282 BOWEL MOVEMENT IRREGULARITY 4 0.0005
283 CARDIOPULMONARY FAILURE 2 0.0005
284 HYPOVOLAEMIA 3 0.0005
285 CORONARY ARTERY OCCLUSION 7 0.0005
286 URINE ODOUR ABNORMAL 3 0.0005
287 AFFECTIVE DISORDER 4 0.0005
288 ENERGY INCREASED 3 0.0005
289 URINARY INCONTINENCE 15 0.0005
290 HOSPICE CARE 5 0.0005
291 LIGAMENT SPRAIN 5 0.0005
292 ACTIVITIES OF DAILY LIVING IMPAIRED 10 0.0005
293 OBESITY 8 0.0005
294 LOW TURNOVER OSTEOPATHY 2 0.0005
295 CARPAL TUNNEL SYNDROME 7 0.0005
296 BLOOD POTASSIUM DECREASED 15 0.0005
297 CANDIDIASIS 2 0.0005
298 GALLBLADDER OPERATION 2 0.0005
299 BACK DISORDER 8 0.0005
300 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 2 0.0005
301 LARYNGEAL OEDEMA 3 0.0005
302 EXTRAVASATION 2 0.0005
303 INFUSION SITE EXTRAVASATION 3 0.0005
304 URINARY RETENTION 16 0.0005
305 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 25 0.0005
306 POOR QUALITY PRODUCT ADMINISTERED 5 0.0005
307 INTESTINAL STENOSIS 2 0.0005
308 MUSCLE FATIGUE 2 0.0005
309 LUNG NEOPLASM 2 0.0005
310 ALCOHOLISM 2 0.0005
311 ERUCTATION 9 0.0005
312 HORDEOLUM 2 0.0005
313 ANGINA UNSTABLE 3 0.0005
314 TARDIVE DYSKINESIA 13 0.0005
315 BONE CANCER 2 0.0005
316 DIVERTICULUM INTESTINAL 2 0.0005
317 DYSPEPSIA 45 0.0005
318 PRODUCT PREPARATION ISSUE 3 0.0005
319 HYPOGAMMAGLOBULINAEMIA 3 0.0005
320 GASTROINTESTINAL PAIN 5 0.0005
321 LUNG INFILTRATION 4 0.0005
322 LIGAMENT RUPTURE 2 0.0005
323 FACIAL PAIN 4 0.0004
324 COLITIS ISCHAEMIC 3 0.0004
325 IRON DEFICIENCY 2 0.0004
326 EYE INFECTION 5 0.0004
327 DRUG EFFECT DELAYED 2 0.0004
328 BLOOD TESTOSTERONE DECREASED 3 0.0004
329 ABDOMINAL HERNIA 2 0.0004
330 CROHN'S DISEASE 3 0.0004
331 GASTRIC DISORDER 15 0.0004
332 LUMBAR VERTEBRAL FRACTURE 2 0.0004
333 ISCHAEMIA 2 0.0004
334 ORAL DISCOMFORT 6 0.0004
335 RENAL FUNCTION TEST ABNORMAL 2 0.0004
336 HEPATIC STEATOSIS 8 0.0004
337 APPLICATION SITE REACTION 3 0.0004
338 PARAESTHESIA ORAL 6 0.0004
339 TONGUE DISORDER 3 0.0004
340 RASH PUSTULAR 3 0.0004
341 FIBROMYALGIA 10 0.0004
342 LIQUID PRODUCT PHYSICAL ISSUE 3 0.0004
343 RENAL CELL CARCINOMA 2 0.0004
344 ARTHROPOD BITE 3 0.0004
345 ABDOMINAL TENDERNESS 2 0.0004
346 EXTRAPYRAMIDAL DISORDER 10 0.0004
347 PANCREATITIS ACUTE 9 0.0004
348 CORONARY ARTERY STENOSIS 2 0.0004
349 PATHOLOGICAL FRACTURE 2 0.0004
350 DRY THROAT 4 0.0004
351 AMMONIA INCREASED 2 0.0004
352 LIPASE INCREASED 3 0.0004
353 VIRAL INFECTION 13 0.0004
354 PHARYNGEAL OEDEMA 6 0.0004
355 ENDOCARDITIS 2 0.0004
356 FOOD ALLERGY 3 0.0004
357 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
358 OSTEOMYELITIS 7 0.0004
359 MULTIPLE ALLERGIES 3 0.0004
360 GINGIVAL PAIN 3 0.0004
361 ANORECTAL DISCOMFORT 2 0.0004
362 BREAST PAIN 4 0.0004
363 COMPRESSION FRACTURE 2 0.0004
364 IRRITABLE BOWEL SYNDROME 8 0.0004
365 SENSORY LOSS 3 0.0004
366 PRODUCT SIZE ISSUE 2 0.0004
367 INTESTINAL RESECTION 2 0.0004
368 POOR QUALITY SLEEP 8 0.0004
369 FLATULENCE 21 0.0004
370 PRURITUS GENERALISED 8 0.0004
371 PRODUCT TASTE ABNORMAL 5 0.0004
372 BLOOD URINE PRESENT 7 0.0004
373 HYDROCEPHALUS 2 0.0004
374 JAW DISORDER 2 0.0004
375 FAECALOMA 2 0.0004
376 PERIPHERAL COLDNESS 5 0.0004
377 CHOKING SENSATION 2 0.0004
378 HYPERKERATOSIS 2 0.0004
379 PROSTATIC DISORDER 2 0.0004
380 FOOT DEFORMITY 4 0.0004
381 PNEUMONIA ASPIRATION 9 0.0004
382 HUNGER 5 0.0004
383 HEART RATE ABNORMAL 2 0.0004
384 BLOOD UREA INCREASED 6 0.0004
385 GLOSSODYNIA 8 0.0004
386 EMOTIONAL DISORDER 11 0.0004
387 THROAT IRRITATION 16 0.0004
388 BLOOD CALCIUM DECREASED 4 0.0004
389 GASTRIC CANCER 9 0.0004
390 PERONEAL NERVE PALSY 2 0.0004
391 PRODUCT AVAILABILITY ISSUE 8 0.0004
392 SINUSITIS 36 0.0004
393 SCAR 6 0.0004
394 INTERNAL HAEMORRHAGE 4 0.0003
395 SPINAL FRACTURE 7 0.0003
396 MUSCULOSKELETAL DISCOMFORT 6 0.0003
397 PSYCHOLOGICAL TRAUMA 3 0.0003
398 HYPOKINESIA 5 0.0003
399 LOCAL SWELLING 6 0.0003
400 NAIL DISORDER 3 0.0003
401 GASTROENTERITIS 5 0.0003
402 RIB FRACTURE 7 0.0003
403 DEPRESSION 77 0.0003
404 EAR INFECTION 9 0.0003
405 CARDIAC PACEMAKER INSERTION 2 0.0003
406 HYPERTENSION 71 0.0003
407 WRIST FRACTURE 4 0.0003
408 HEARING IMPAIRED 2 0.0003
409 ABDOMINAL PAIN UPPER 68 0.0003
410 OPTIC NEURITIS 3 0.0003
411 EXOSTOSIS 3 0.0003
412 RETCHING 7 0.0003
413 NO THERAPEUTIC RESPONSE 4 0.0003
414 RESTLESSNESS 12 0.0003
415 INCREASED TENDENCY TO BRUISE 3 0.0003
416 MENISCUS INJURY 2 0.0003
417 NERVE COMPRESSION 3 0.0003
418 SPINAL OPERATION 4 0.0003
419 PIGMENTATION DISORDER 2 0.0003
420 ARTHROPATHY 18 0.0003
421 MUSCULOSKELETAL CHEST PAIN 5 0.0003
422 ANKLE FRACTURE 5 0.0003
423 TENDONITIS 5 0.0003
424 OLIGURIA 2 0.0003
425 DEFORMITY 3 0.0003
426 SECRETION DISCHARGE 4 0.0003
427 ARTERIOSCLEROSIS 3 0.0003
428 MULTIPLE INJURIES 2 0.0003
429 PRODUCT USE COMPLAINT 5 0.0003
430 HYPOCALCAEMIA 6 0.0003
431 INCREASED APPETITE 6 0.0003
432 FOREIGN BODY SENSATION IN EYES 2 0.0003
433 HYPOPHAGIA 8 0.0003
434 ORAL PAIN 7 0.0003
435 ENTERITIS 2 0.0003
436 DIZZINESS POSTURAL 3 0.0003
437 ANXIETY 88 0.0003
438 EAR PAIN 6 0.0003
439 APPLICATION SITE VESICLES 2 0.0003
440 DRUG SPECIFIC ANTIBODY PRESENT 2 0.0003
441 PHARYNGEAL SWELLING 3 0.0003
442 ANHEDONIA 8 0.0003
443 BLADDER DISORDER 3 0.0003
444 APPETITE DISORDER 2 0.0003
445 PSYCHOMOTOR HYPERACTIVITY 5 0.0003
446 BLOOD CHOLESTEROL INCREASED 14 0.0003
447 CORONARY ARTERY DISEASE 9 0.0003
448 TOOTH ABSCESS 3 0.0003
449 ARTHRITIS 23 0.0003
450 INITIAL INSOMNIA 3 0.0003
451 CENTRAL NERVOUS SYSTEM LESION 4 0.0003
452 LYMPHOEDEMA 2 0.0003
453 LARGE INTESTINE POLYP 2 0.0003
454 ABDOMINAL PAIN 67 0.0003
455 WEIGHT FLUCTUATION 3 0.0003
456 EXTRASYSTOLES 2 0.0003
457 PRODUCT ODOUR ABNORMAL 3 0.0003
458 DEFAECATION URGENCY 2 0.0003
459 KNEE ARTHROPLASTY 6 0.0003
460 JOINT DISLOCATION 3 0.0003
461 EYE PAIN 16 0.0003
462 ABASIA 7 0.0003
463 HYPOKALAEMIA 13 0.0003
464 HIP FRACTURE 9 0.0003
465 PHARYNGITIS STREPTOCOCCAL 3 0.0003
466 DEEP VEIN THROMBOSIS 18 0.0003
467 SKIN LACERATION 3 0.0003
468 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
469 PELVIC PAIN 5 0.0003
470 FLUID OVERLOAD 4 0.0003
471 ASPIRATION 3 0.0003
472 DENTAL CARIES 3 0.0003
473 BLINDNESS TRANSIENT 2 0.0003
474 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
475 PULMONARY MASS 4 0.0003
476 MUSCULOSKELETAL PAIN 14 0.0003
477 TRANSIENT ISCHAEMIC ATTACK 9 0.0003
478 PHOTOPHOBIA 5 0.0003
479 HEART RATE IRREGULAR 6 0.0003
480 HYPOAESTHESIA ORAL 4 0.0003
481 PAROSMIA 2 0.0003
482 IMPAIRED DRIVING ABILITY 3 0.0003
483 MYOCARDIAL ISCHAEMIA 3 0.0003
484 DERMATITIS CONTACT 3 0.0003
485 SCAB 3 0.0003
486 INSURANCE ISSUE 4 0.0003
487 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
488 THROMBOSIS 21 0.0003
489 PRODUCT USE ISSUE 49 0.0003
490 PRODUCT SUBSTITUTION ISSUE 15 0.0003
491 SEROTONIN SYNDROME 5 0.0003
492 DRUG EFFECT DECREASED 14 0.0003
493 DEVICE RELATED INFECTION 4 0.0003
494 UPPER RESPIRATORY TRACT INFECTION 12 0.0003
495 OSTEOARTHRITIS 11 0.0003
496 OROPHARYNGEAL PAIN 24 0.0003
497 CHEST PAIN 48 0.0003
498 ELECTROLYTE IMBALANCE 3 0.0003
499 PELVIC FRACTURE 2 0.0003
500 HYPERKALAEMIA 9 0.0003
501 RECTAL HAEMORRHAGE 11 0.0003
502 DYSGEUSIA 19 0.0003
503 GASTROINTESTINAL INFLAMMATION 2 0.0003
504 DRUG SCREEN POSITIVE 2 0.0003
505 HEAD INJURY 8 0.0003
506 MENTAL DISORDER 11 0.0003
507 DIVERTICULITIS 7 0.0003
508 BLOOD ALBUMIN DECREASED 2 0.0003
509 PRODUCTIVE COUGH 12 0.0003
510 UPPER LIMB FRACTURE 5 0.0003
511 ATRIAL FLUTTER 2 0.0003
512 CONSTIPATION 54 0.0002
513 PRODUCT ADMINISTRATION ERROR 5 0.0002
514 ADRENAL INSUFFICIENCY 3 0.0002
515 MUSCLE DISORDER 2 0.0002
516 DYSKINESIA 10 0.0002
517 PANCREATITIS 13 0.0002
518 FLUSHING 25 0.0002
519 SWELLING FACE 16 0.0002
520 DECUBITUS ULCER 2 0.0002
521 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
522 ANGINA PECTORIS 7 0.0002
523 HICCUPS 2 0.0002
524 BRONCHITIS 18 0.0002
525 INJECTION SITE EXTRAVASATION 3 0.0002
526 ESCHERICHIA INFECTION 2 0.0002
527 STAPHYLOCOCCAL INFECTION 8 0.0002
528 BURNING SENSATION 17 0.0002
529 ACUTE CORONARY SYNDROME 2 0.0002
530 ILEUS 3 0.0002
531 HYPOAESTHESIA 36 0.0002
532 FUNGAL INFECTION 8 0.0002
533 TINNITUS 11 0.0002
534 INTENTIONAL DRUG MISUSE 5 0.0002
535 CELLULITIS 12 0.0002
536 TYPE 2 DIABETES MELLITUS 8 0.0002
537 TREMOR 39 0.0002
538 ANOREXIA 3 0.0002
539 CARDIAC OPERATION 2 0.0002
540 NECK PAIN 13 0.0002
541 SKIN ULCER 6 0.0002
542 MYOPATHY 2 0.0002
543 NEUROPATHY PERIPHERAL 22 0.0002
544 CARDIAC MURMUR 2 0.0002
545 ABDOMINAL DISTENSION 24 0.0002
546 OEDEMA PERIPHERAL 28 0.0002
547 ORTHOSTATIC HYPOTENSION 4 0.0002
548 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
549 JOINT STIFFNESS 6 0.0002
550 GROIN PAIN 2 0.0002
551 SYSTEMIC LUPUS ERYTHEMATOSUS 8 0.0002
552 UNEVALUABLE EVENT 17 0.0002
553 THIRST 4 0.0002
554 BACK PAIN 52 0.0002
555 HAEMARTHROSIS 2 0.0002
556 GASTROINTESTINAL INFECTION 2 0.0002
557 DISTURBANCE IN ATTENTION 12 0.0002
558 ANAL INCONTINENCE 2 0.0002
559 SINUS CONGESTION 3 0.0002
560 GASTROENTERITIS VIRAL 4 0.0002
561 CHROMATURIA 5 0.0002
562 PAIN 136 0.0002
563 DYSPHAGIA 21 0.0002
564 TOOTHACHE 4 0.0002
565 LIMB INJURY 6 0.0002
566 MIGRAINE 21 0.0002
567 AKATHISIA 3 0.0002
568 CYSTITIS 7 0.0002
569 PANIC ATTACK 8 0.0002
570 METABOLIC ACIDOSIS 7 0.0002
571 WEIGHT DECREASED 61 0.0002
572 RETINAL DETACHMENT 2 0.0002
573 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
574 ANAPHYLACTIC REACTION 12 0.0002
575 PRODUCT STORAGE ERROR 19 0.0002
576 MUSCLE TWITCHING 5 0.0002
577 IRON DEFICIENCY ANAEMIA 2 0.0002
578 GRAND MAL CONVULSION 2 0.0002
579 PROCEDURAL PAIN 6 0.0002
580 THINKING ABNORMAL 4 0.0002
581 DIARRHOEA HAEMORRHAGIC 2 0.0002
582 NAUSEA 169 0.0002
583 FLANK PAIN 2 0.0002
584 INCORRECT DRUG ADMINISTRATION DURATION 6 0.0002
585 DEVICE OCCLUSION 3 0.0002
586 MUSCLE SPASMS 39 0.0002
587 BLOOD SODIUM DECREASED 4 0.0002
588 RENAL FAILURE ACUTE 9 0.0002
589 PAIN IN JAW 6 0.0002
590 MUSCULAR WEAKNESS 24 0.0002
591 OCULAR HYPERAEMIA 10 0.0002
592 PRODUCT PACKAGING ISSUE 2 0.0002
593 DRY MOUTH 17 0.0002
594 HYPERSOMNIA 6 0.0002
595 HEADACHE 131 0.0002
596 PULMONARY FIBROSIS 4 0.0002
597 HYPERCHOLESTEROLAEMIA 2 0.0002
598 PULMONARY ARTERIAL HYPERTENSION 3 0.0002
599 ANGER 7 0.0002
600 LIVER FUNCTION TEST ABNORMAL 6 0.0002
601 MENTAL IMPAIRMENT 5 0.0002
602 DYSTONIA 4 0.0002
603 HAEMORRHOIDS 4 0.0002
604 BONE PAIN 12 0.0002
605 EMBEDDED DEVICE 2 0.0002
606 HAEMATOCRIT DECREASED 4 0.0002
607 CATARACT 12 0.0002
608 TREATMENT NONCOMPLIANCE 11 0.0002
609 OVARIAN CYST 2 0.0002
610 URINARY TRACT INFECTION 34 0.0002
611 PRODUCT PHYSICAL ISSUE 4 0.0002
612 EMOTIONAL DISTRESS 24 0.0002
613 ABDOMINAL PAIN LOWER 5 0.0002
614 CONTUSION 19 0.0002
615 FEEDING DISORDER 4 0.0002
616 EYELID PTOSIS 2 0.0002
617 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 14 0.0002
618 ABDOMINAL DISCOMFORT 33 0.0002
619 DISCOMFORT 12 0.0002
620 DRUG LEVEL DECREASED 2 0.0002
621 HIP ARTHROPLASTY 3 0.0002
622 DEHYDRATION 26 0.0002
623 EAR DISCOMFORT 2 0.0002
624 THYROID DISORDER 3 0.0002
625 HYPERHIDROSIS 25 0.0002
626 ANAEMIA 37 0.0002
627 RHEUMATOID ARTHRITIS 22 0.0002
628 DELUSION 3 0.0002
629 RASH GENERALISED 5 0.0002
630 TOOTH LOSS 4 0.0002
631 WRONG TECHNIQUE IN DRUG USAGE PROCESS 7 0.0002
632 COUGH 54 0.0002
633 EYE DISCHARGE 2 0.0002
634 SWOLLEN TONGUE 6 0.0002
635 SPEECH DISORDER 10 0.0002
636 CYANOSIS 3 0.0002
637 MOUTH ULCERATION 4 0.0002
638 ULCER 3 0.0002
639 MOOD SWINGS 6 0.0002
640 BODY HEIGHT DECREASED 2 0.0002
641 CARDIAC FAILURE CONGESTIVE 15 0.0002
642 DYSARTHRIA 7 0.0002
643 DYSPNOEA EXERTIONAL 7 0.0002
644 INTESTINAL OBSTRUCTION 7 0.0002
645 HYPOGLYCAEMIA 9 0.0002
646 WHEEZING 11 0.0002
647 MUSCLE TIGHTNESS 3 0.0002
648 ATRIAL FIBRILLATION 18 0.0002
649 FAECES DISCOLOURED 4 0.0002
650 AMNESIA 12 0.0002
651 BIPOLAR DISORDER 2 0.0002
652 BACK INJURY 2 0.0002
653 DIABETES MELLITUS 14 0.0002
654 BLOOD PRESSURE INCREASED 28 0.0002
655 MEMORY IMPAIRMENT 25 0.0002
656 MELAENA 4 0.0002
657 INJECTION SITE NODULE 2 0.0002
658 SWELLING 17 0.0002
659 INFUSION RELATED REACTION 12 0.0002
660 PLEURAL EFFUSION 11 0.0002
661 VISUAL ACUITY REDUCED 6 0.0002
662 EXPIRED PRODUCT ADMINISTERED 6 0.0002
663 LIP SWELLING 6 0.0002
664 FEELING HOT 11 0.0002
665 VOMITING 84 0.0002
666 BLISTER 10 0.0002
667 CANDIDA INFECTION 3 0.0002
668 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 32 0.0002
669 VISUAL IMPAIRMENT 22 0.0002
670 DIARRHOEA 114 0.0002
671 APPLICATION SITE PRURITUS 4 0.0002
672 JOINT SWELLING 21 0.0002
673 SOMNOLENCE 35 0.0002
674 CARDIAC DISORDER 16 0.0002
675 DYSPHONIA 10 0.0002
676 BLOOD TRIGLYCERIDES INCREASED 3 0.0002
677 WEIGHT INCREASED 38 0.0002
678 DRUG DOSE OMISSION 28 0.0002
679 DRUG ERUPTION 3 0.0002
680 INSOMNIA 45 0.0002
681 ARRHYTHMIA 8 0.0002
682 TACHYCARDIA 15 0.0002
683 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
684 BACTERAEMIA 2 0.0002
685 FEELING ABNORMAL 40 0.0002
686 BLOOD PRESSURE FLUCTUATION 4 0.0002
687 PAIN IN EXTREMITY 49 0.0002
688 LACRIMATION INCREASED 5 0.0002
689 LOCALISED INFECTION 4 0.0002
690 BURSITIS 2 0.0002
691 ILL-DEFINED DISORDER 10 0.0002
692 NEURALGIA 4 0.0002
693 DIZZINESS 82 0.0002
694 FATIGUE 127 0.0002
695 INJECTION SITE URTICARIA 4 0.0002
696 CARDIOMEGALY 2 0.0002
697 PERIPHERAL SWELLING 25 0.0002
698 PALPITATIONS 19 0.0002
699 PRODUCT QUALITY ISSUE 22 0.0002
700 HYPERCALCAEMIA 2 0.0002
701 GENERALISED OEDEMA 2 0.0002
702 DYSPNOEA 91 0.0002
703 AGEUSIA 4 0.0002
704 DRY EYE 8 0.0002
705 VISION BLURRED 22 0.0002
706 OXYGEN SATURATION DECREASED 9 0.0002
707 BONE DENSITY DECREASED 5 0.0002
708 PRURITUS 61 0.0002
709 MUSCLE ATROPHY 2 0.0002
710 GASTRIC ULCER 3 0.0002
711 MUSCULOSKELETAL DISORDER 3 0.0002
712 MALAISE 69 0.0002
713 FLUID RETENTION 8 0.0002
714 INJECTION SITE IRRITATION 2 0.0002
715 GAIT DISTURBANCE 30 0.0002
716 HYPOTHYROIDISM 5 0.0002
717 LETHARGY 9 0.0002
718 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
719 CHEST DISCOMFORT 16 0.0002
720 POST PROCEDURAL COMPLICATION 3 0.0002
721 DRUG PRESCRIBING ERROR 3 0.0002
722 LOSS OF CONSCIOUSNESS 20 0.0002
723 SLEEP DISORDER 11 0.0002
724 MOVEMENT DISORDER 5 0.0002
725 HERNIA 3 0.0002
726 RHINORRHOEA 10 0.0002
727 DRUG INEFFECTIVE 203 0.0002
728 ARTHRALGIA 64 0.0002
729 CHOKING 3 0.0002
730 ORAL HERPES 3 0.0002
731 RESPIRATORY TRACT INFECTION 4 0.0002
732 CEREBROVASCULAR ACCIDENT 26 0.0002
733 NODULE 2 0.0002
734 NERVOUSNESS 8 0.0002
735 APPLICATION SITE ERYTHEMA 4 0.0002
736 SKIN DISCOLOURATION 7 0.0002
737 BEDRIDDEN 2 0.0002
738 PULMONARY CONGESTION 2 0.0002
739 BLOOD PRESSURE DECREASED 10 0.0002
740 ASTHMA 17 0.0002
741 BALANCE DISORDER 13 0.0002
742 PRESCRIBED UNDERDOSE 3 0.0002
743 HAIR TEXTURE ABNORMAL 2 0.0001
744 MALIGNANT MELANOMA 2 0.0001
745 FULL BLOOD COUNT DECREASED 3 0.0001
746 FEAR 4 0.0001
747 EXTRA DOSE ADMINISTERED 6 0.0001
748 FREQUENT BOWEL MOVEMENTS 4 0.0001
749 TASTE DISORDER 3 0.0001
750 DECREASED APPETITE 34 0.0001
751 MULTIPLE SCLEROSIS RELAPSE 10 0.0001
752 SKIN LESION 4 0.0001
753 BLOOD GLUCOSE DECREASED 7 0.0001
754 GASTROINTESTINAL DISORDER 13 0.0001
755 NIGHTMARE 5 0.0001
756 FALL 48 0.0001
757 RHABDOMYOLYSIS 6 0.0001
758 ASTHENIA 54 0.0001
759 HAEMOPTYSIS 4 0.0001
760 MYOCARDIAL INFARCTION 25 0.0001
761 APHONIA 2 0.0001
762 DERMATITIS 3 0.0001
763 DEMENTIA 4 0.0001
764 WITHDRAWAL SYNDROME 6 0.0001
765 HEART RATE INCREASED 14 0.0001
766 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
767 EATING DISORDER 3 0.0001
768 IMPAIRED WORK ABILITY 3 0.0001
769 MOBILITY DECREASED 10 0.0001
770 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
771 ANOSMIA 2 0.0001
772 INJECTION SITE HAEMATOMA 2 0.0001
773 PRODUCT DISPENSING ERROR 3 0.0001
774 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
775 PULMONARY EMBOLISM 13 0.0001
776 THERAPY CESSATION 7 0.0001
777 NASAL CONGESTION 8 0.0001
778 PNEUMONIA 44 0.0001
779 NASOPHARYNGITIS 25 0.0001
780 CARDIOMYOPATHY 2 0.0001
781 MYALGIA 23 0.0001
782 TOOTH DISORDER 3 0.0001
783 RASH MACULO-PAPULAR 3 0.0001
784 NEOPLASM MALIGNANT 9 0.0001
785 COLON CANCER 2 0.0001
786 RASH PAPULAR 3 0.0001
787 BONE LOSS 2 0.0001
788 HOT FLUSH 10 0.0001
789 APHASIA 4 0.0001
790 DEPRESSED MOOD 7 0.0001
791 HEPATIC ENZYME INCREASED 9 0.0001
792 COLITIS 5 0.0001
793 DEVICE FAILURE 2 0.0001
794 DRUG DISPENSING ERROR 2 0.0001
795 DRUG ADMINISTRATION ERROR 4 0.0001
796 PERICARDIAL EFFUSION 3 0.0001
797 LIMB DISCOMFORT 4 0.0001
798 FEMUR FRACTURE 4 0.0001
799 LUNG INFECTION 2 0.0001
800 ACUTE MYELOID LEUKAEMIA 2 0.0001
801 PLASMA CELL MYELOMA 5 0.0001
802 BLOOD GLUCOSE INCREASED 24 0.0001
803 PARAESTHESIA 20 0.0001
804 RENAL CANCER 6 0.0001
805 SCIATICA 2 0.0001
806 ABSCESS 2 0.0001
807 INFECTION 18 0.0001
808 HYPONATRAEMIA 7 0.0001
809 RESPIRATORY FAILURE 9 0.0001
810 BLOOD POTASSIUM INCREASED 2 0.0001
811 INCORRECT DOSE ADMINISTERED 28 0.0001
812 DEVICE ISSUE 11 0.0001
813 PRODUCT DOSE OMISSION 8 0.0001
814 CONVULSION 7 0.0001
815 ENCEPHALOPATHY 3 0.0001
816 CONDITION AGGRAVATED 37 0.0001
817 MANIA 2 0.0001
818 OSTEONECROSIS OF JAW 3 0.0001
819 SYNCOPE 12 0.0001
820 HYPERSENSITIVITY 22 0.0001
821 HAEMATEMESIS 3 0.0001
822 HEMIPARESIS 2 0.0001
823 CONFUSIONAL STATE 19 0.0001
824 HOSPITALISATION 18 0.0001
825 HAEMOGLOBIN DECREASED 12 0.0001
826 ERECTILE DYSFUNCTION 3 0.0001
827 INFLUENZA 13 0.0001
828 ANAPHYLACTIC SHOCK 3 0.0001
829 INFLAMMATION 6 0.0001
830 UNRESPONSIVE TO STIMULI 3 0.0001
831 HAEMATOMA 3 0.0001
832 MULTI-ORGAN FAILURE 2 0.0001
833 THERAPEUTIC RESPONSE DECREASED 7 0.0001
834 STOMATITIS 7 0.0001
835 SEPTIC SHOCK 5 0.0001
836 VERTIGO 7 0.0001
837 HAEMORRHAGE 12 0.0001
838 DEAFNESS 3 0.0001
839 INTENTIONAL PRODUCT MISUSE 10 0.0001
840 METASTASES TO LIVER 2 0.0001
841 DERMATITIS ATOPIC 6 0.0001
842 COLD SWEAT 2 0.0001
843 BRADYCARDIA 6 0.0001
844 ANGIOEDEMA 5 0.0001
845 INJECTION SITE HAEMORRHAGE 9 0.0001
846 PRODUCT DOSE OMISSION ISSUE 33 0.0001
847 PRODUCT ADHESION ISSUE 4 0.0001
848 PULMONARY OEDEMA 5 0.0001
849 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
850 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
851 THROAT TIGHTNESS 3 0.0001
852 CHILLS 13 0.0001
853 RASH PRURITIC 6 0.0001
854 OEDEMA 6 0.0001
855 SUICIDAL IDEATION 10 0.0001
856 HAEMATOCHEZIA 6 0.0001
857 MENTAL STATUS CHANGES 3 0.0001
858 FEELING COLD 3 0.0001
859 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
860 COGNITIVE DISORDER 5 0.0001
861 FRACTURE 2 0.0001
862 INTENTIONAL DOSE OMISSION 3 0.0001
863 MULTIPLE SCLEROSIS 5 0.0001
864 EYE IRRITATION 6 0.0001
865 LOWER LIMB FRACTURE 2 0.0001
866 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
867 ACUTE RESPIRATORY FAILURE 2 0.0001
868 PANCREATIC CARCINOMA 3 0.0001
869 PRESCRIBED OVERDOSE 2 0.0001
870 DYSSTASIA 3 0.0001
871 COVID-19 18 0.0001
872 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
873 LUNG DISORDER 5 0.0001
874 ACUTE MYOCARDIAL INFARCTION 3 0.0001
875 DISABILITY 2 0.0001
876 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
877 INJECTION SITE PAIN 31 0.0001
878 BLOOD PRESSURE ABNORMAL 2 0.0001
879 RESPIRATORY DISORDER 3 0.0001
880 INJECTION SITE BRUISING 8 0.0001
881 ADVERSE DRUG REACTION 9 0.0001
882 AGGRESSION 5 0.0001
883 IRRITABILITY 6 0.0001
884 SEPSIS 11 0.0001
885 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 7 0.0001
886 ERYTHEMA 20 0.0001
887 ILLNESS 10 0.0001
888 PULMONARY HYPERTENSION 2 0.0001
889 ROAD TRAFFIC ACCIDENT 4 0.0001
890 PYREXIA 33 0.0001
891 SKIN EXFOLIATION 8 0.0001
892 RASH 41 0.0001
893 JOINT INJURY 2 0.0001
894 EPISTAXIS 7 0.0001
895 LIVER FUNCTION TEST INCREASED 2 0.0001
896 HYPOACUSIS 4 0.0001
897 HALLUCINATION 7 0.0001
898 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
899 DEVICE LEAKAGE 4 0.0001
900 BLOOD CREATININE INCREASED 6 0.0001
901 INJECTION SITE SWELLING 7 0.0001
902 MUSCULOSKELETAL STIFFNESS 8 0.0001
903 APPLICATION SITE PAIN 2 0.0001
904 MEDICATION ERROR 5 0.0001
905 URTICARIA 15 0.0001
906 COLITIS ULCERATIVE 4 0.0001
907 NEOPLASM PROGRESSION 3 0.0001
908 RASH MACULAR 3 0.0001
909 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 2 0.0001
910 DISEASE RECURRENCE 4 0.0001
911 PRODUCT PRESCRIBING ERROR 2 0.0001
912 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 17 0.0001
913 CEREBRAL HAEMORRHAGE 3 0.0001
914 SKIN BURNING SENSATION 6 0.0001
915 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
916 DRUG EFFECT INCOMPLETE 3 0.0001
917 C-REACTIVE PROTEIN INCREASED 3 0.0001
918 DEATH 71 0.0001
919 PRESYNCOPE 2 0.0001
920 ACCIDENTAL OVERDOSE 3 0.0001
921 DRUG INTERACTION 13 0.0001
922 INJECTION SITE MASS 3 0.0001
923 LEUKOPENIA 4 0.0001
924 CARDIOVASCULAR DISORDER 2 0.0001
925 GENERAL PHYSICAL HEALTH DETERIORATION 9 0.0001
926 DIPLOPIA 2 0.0001
927 ECZEMA 4 0.0001
928 ALOPECIA 15 0.0001
929 ABNORMAL BEHAVIOUR 3 0.0001
930 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
931 BREAST CANCER FEMALE 2 0.0001
932 HYPOTENSION 15 0.0001
933 CARDIAC FAILURE 6 0.0001
934 PAIN OF SKIN 2 0.0001
935 BLINDNESS 3 0.0001
936 OFF LABEL USE 64 0.0001
937 LUNG NEOPLASM MALIGNANT 3 0.0001
938 INFLUENZA LIKE ILLNESS 6 0.0001
939 INJECTION SITE ERYTHEMA 9 0.0001
940 RESPIRATORY DISTRESS 2 0.0001
941 ABNORMAL DREAMS 2 0.0001
942 THERAPY INTERRUPTED 5 0.0001
943 RED BLOOD CELL COUNT DECREASED 2 0.0001
944 VAGINAL HAEMORRHAGE 3 0.0001
945 PSORIASIS 9 0.0001
946 AGITATION 5 0.0001
947 ASCITES 2 0.0001
948 PSYCHOTIC DISORDER 2 0.0001
949 THERAPY NON-RESPONDER 3 0.0001
950 ACNE 5 0.0001
951 INJECTION SITE RASH 2 0.0001
952 NERVOUS SYSTEM DISORDER 2 0.0001
953 COMA 3 0.0001
954 RASH ERYTHEMATOUS 3 0.0001
955 INTERSTITIAL LUNG DISEASE 3 0.0001
956 SEIZURE 7 0.0001
957 DRY SKIN 8 0.0001
958 EYE PRURITUS 2 0.0001
959 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
960 INJECTION SITE REACTION 4 0.0001
961 DELIRIUM 2 0.0001
962 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
963 HEART RATE DECREASED 2 0.0001
964 DEVICE MALFUNCTION 4 0.0001
965 LYMPHADENOPATHY 2 0.0001
966 NO ADVERSE EVENT 10 0.0001
967 CRYING 2 0.0001
968 UNDERDOSE 4 0.0001
969 THROMBOCYTOPENIA 6 0.0001
970 BREAST CANCER 5 0.0001
971 HERPES ZOSTER 3 0.0001
972 DISORIENTATION 2 0.0001
973 NEUTROPHIL COUNT DECREASED 2 0.0000
974 CARDIAC ARREST 4 0.0000
975 PLATELET COUNT DECREASED 5 0.0000
976 OVERDOSE 10 0.0000
977 DEVICE DIFFICULT TO USE 3 0.0000
978 FEBRILE NEUTROPENIA 3 0.0000
979 INJECTION SITE PRURITUS 3 0.0000
980 ADVERSE EVENT 4 0.0000
981 DISEASE PROGRESSION 5 0.0000
982 PRODUCT USE IN UNAPPROVED INDICATION 10 0.0000
983 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
984 DRUG DEPENDENCE 6 0.0000
985 NEUTROPENIA 5 0.0000
986 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
987 TREATMENT FAILURE 3 0.0000
988 PANCYTOPENIA 2 0.0000
989 DRUG WITHDRAWAL SYNDROME 3 0.0000
990 BLADDER CANCER 2 0.0000
991 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
992 DRUG INTOLERANCE 3 0.0000
993 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000